Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port
Breast Cancer · 2024
DOI: 10.1007/s12282-024-01608-z ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Breast Cancer, 2024. Verfasst von Fulvio Pinelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Access Center, Department of Anesthesia and Intensive Care, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy. Hauptthemen laut MEDLINE: Quality of Life, Breast Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Peripherally inserted central catheters (PICCs) and new type of arm-port, the PICC-port, are currently used for neoadjuvant chemotherapy treatment in patients with breast cancer. We aimed to compare Quality of Life (QoL) of patients receiving one of these two devices investigating overall satisfaction, psychological impact, as well as the impact on professional, social and sport activities, and local discomfort.
Methods
We did a prospective observational before–after study of PICCs versus PICC-ports. Adult (aged ≥ 18 years) females with breast cancer candidate to neoadjuvant chemotherapy were included. The primary outcome was QoL according to the Quality-of-Life Assessment Venous Device Catheters (QLAVD) questionnaire assessed 12 months after device implantation.
Results
Between May 2019 and November 2020, of 278 individuals screened for eligibility, 210 were enrolled. PICC-ports were preferred over PICCs with a QLAVD score of 29 [25; 32] vs 31 [26; 36.5] ( p = 0.014). Specifically, most QLAVD constructs related to psychological impact, social aspects, and discomfort were in favor of PICC-ports vs PICC, especially in women under the age of 60. Overall, pain scores at insertion and during therapy administration were not significantly different between the two groups, as well as infection, secondary malpositioning, thrombosis, or obstruction of the device.
Conclusions
In women with breast cancer undergoing neoadjuvant chemotherapy, PICC-ports were overall better accepted than PICCs in terms of QoL, especially in those who were younger. Device-related complications were similar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Access Center, Department of Anesthesia and Intensive Care, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.
- Department of Nursing, Careggi University Hospital, Florence, Italy.
- Department of Health Sciences (DSS), Section of Anesthesiology, Intensive Care and Pain Medicine, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy.
- Department of Health Sciences (DSS), University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy. gianluca.villa@unifi.it.
Förderung
- Università degli Studi di Firenze
Zitieren
APA
Pinelli, F., Barbani, F., Defilippo, B., Fundarò, A., Nella, A., Selmi, V., Romagnoli, S., & Villa, G. (2024). Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port. Breast Cancer. https://doi.org/10.1007/s12282-024-01608-z
Vancouver
Pinelli F, Barbani F, Defilippo B, Fundarò A, Nella A, Selmi V, et al. Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port. Breast Cancer. 2024. doi:10.1007/s12282-024-01608-z
BibTeX
@article{Pinelli2024,
author = {Pinelli, Fulvio and Barbani, Francesco and Defilippo, Barbara and Fundarò, Angela and Nella, Alessandra and Selmi, Valentina and Romagnoli, Stefano and Villa, Gianluca},
title = {Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port},
journal = {Breast Cancer},
year = {2024},
doi = {10.1007/s12282-024-01608-z}
}
EUVIMED